© 2021 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2021 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
July 19, 2021
After the largest increase in overdose deaths in 50 years, the American Psychiatric Association sends out the call for improved substance use care.
July 15, 2021
Novel digital therapy modia will be evaluated in combination with sublingual buprenorphine/naloxone background therapy to see whether it is superior in reducing opioid use.
June 23, 2021
The enduring racial gap in the opiate addiction rate stems largely from racist 19th-century medical beliefs about Black bodies, coupled with substandard medical care provided to Black Civil War troops.
June 22, 2021
Adial’s AD04 for the treatment of alcohol use disorder received a Notice of Allowance from the US Patent and Trademark Office.
June 01, 2021
How can understanding the opioid crisis in Canada inform strategies in the United States?
May 03, 2021
According to Nora D. Volkow, MD, Director of the National Institute on Drug Abuse, drug use and overdose deaths have significantly increased since the outset of the pandemic. What made it worse?
April 30, 2021
The FDA approved a higher dose of naloxone to treat opioid overdose deaths.
March 19, 2021
How can we save more lives and prevent overdose deaths? Lloyd I Sederer, MD, a psychiatrist, expert in public health, and author provides insights.
February 25, 2021
Black soldiers’ lack of access to opiate analgesics and antidiarrheals was typical, not exceptional, when considered within the broader scheme of Civil War medicine.
January 21, 2021
With opioid use disorder, a tiny fraction of young patients are getting treatment, which would not be acceptable for any other medical condition.